We are pleased to announce that Prof. Dr. Vyacheslav Yurchenko has been appointed Editor-in-Chief of the Section "Neglected and Emerging Tropical Disease" Section in Tropical Medicine and Infectious Disease (IF: 3.711, ISSN: 2414-6366).
Prof. Dr. Vyacheslav Yurchenko is the head of the Laboratory of Trypanosomatid Biology at the University of Ostrava. He obtained his Ph.D. degree in molecular biology at Moscow State University in 1999 and has published almost 150 papers in international peer-reviewed journals. Prof. Dr. Yurchenko is currently serving on the Editorial Boards of over 10 journals. His current research topics include studies on trypanosomatidae with a focus on human pathogen Leishmania spp.; the evolution of monoxenous trypanosomatids; trypanosomatids viruses and endosymbionts; RNA editing in non-model flagellates; mechanisms of translation and features of the alternative genetic code in these parasites; and evolutionary genomics of model and non-model species.
|
|
The following is a short Q&A with Prof. Dr. Vyacheslav Yurchenko, who shared his vision for the journal with us, as well as his views of the research area and open access publishing:
1. What appealed to you about this journal that made you want to take on the role as its Section Editor-in-Chief?
I have been involved with the journal, as an Editorial Board Member, since 2019. The steady growth of the journal’s reputation and the numerous excellent papers published in Tropical Medicine and Infectious Disease over the years were the decisive factors in me taking on the role of its Section Editor-in-Chief.
2. What is your vision for the journal?
I will do my best to make Tropical Medicine and Infectious Disease even more prominent. This will be achieved by a stringent review process allowing us to publish high-profile seminal papers, which will have an impact on the field at large.
3. What does the future of this field of research look like?
In my opinion, the future of the field of neglected and emerging tropical diseases lies in the complex approach to the questions involved. Neither phenotypical nor molecular nor genomics/transcriptomics studies alone will be considered comprehensive enough in the near future.
4. What do you think of the development of open access in the publishing field?
I sincerely believe this is the right way to go forward. Publishing papers in the open access model makes them available to a wider circle of professionals; this, in turn, leads to greater dissemination of scientific results and, as a result, the faster advancement of the field.
We wish Prof. Dr. Vyacheslav Yurchenko every success in his new position, and we look forward to his contributions to the journal.